• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 469405 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414678371 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414678371 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock to Watch: Novabay Pharmaceuticals Up 8.6% (NBY)

Published on Mon, 04/01/2013 - 12:24
By Adrienne Chilton

Novabay Pharmaceuticals (AMEX:NBY) is one of today's best performing low-priced stocks, up 8.6% to $1.52 on 3.8x average daily volume. Thus far today, Novabay Pharmaceuticals has traded 921,000 shares, vs. average volume of 240,000 shares per day. The stock has outperformed the Dow (8.6% to the Dow's -0.0%) and outperformed the S&P 500 (8.6% to the S&P's -0.4%) during today's trading.

Potential upside of 48.0% exists for Novabay Pharmaceuticals, based on a current level of $1.52 and analysts' average consensus price target of $2.25. The stock should find initial support at its 200-day moving average (MA) of $1.25 and further support at its 50-day MA of $1.24.

Novabay Pharmaceuticals Inc. is a biopharmaceutical company focused on developing product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. The Company has developed a class of antimicrobial compounds for use in the treatment and prevention of bacterial infections.

In the past 52 weeks, Novabay Pharmaceuticals share prices have been bracketed by a low of $0.88 and a high of $1.76 and are now at $1.52, 73% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 1.0%.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Clicksoftware Technologies Defies the Ra...

A week ago, Lake Street downgraded Clicksoftware Technologies from Buy to Hold. Clicks ...

Citrix Systems Down 2.7% Since Drexel Ha...

One week ago Citrix Systems (NASDAQ:CTXS) was downgraded from Buy to Hold at Drexel Ham ...

Pan American Silver Down 0.4% Since Raym...

Pan American Silver was upgraded from Market Perform to Outperform by Raymond James one ...

Analyst Rating Flashback: ICON Down 5.6%...

A week ago, First Analysis downgraded ICON from Overweight to Equal Weight. The shares ...

Tractor Supply Fulfills the Promise: Up ...

One week ago Tractor Supply (NASDAQ:TSCO) was upgraded from Market Perform to Strong Bu ...

Melco Crown Entertainment Up 2.2% Since ...

One week ago Melco Crown Entertainment (NASDAQ:MPEL) was downgraded from Buy to Neutral ...

Oracle Up 2.5% Since Tigress Financial D...

Oracle was downgraded from Buy to Neutral by Tigress Financial one week ago. Oracle st ...

DTS Inc In Retrospect: Shares Up 3.6% Si...

DTS Inc was downgraded from Neutral to Underweight by JP Morgan one week ago. The stoc ...